Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early and Late Neutrophil CD64 and Monocyte HLA-DR as Biomarkers for Septic Shock

NCT07401329 is registered in ClinicalTrials.gov with Pandit Bhagwat Dayal Sharma, PGIMS, Rohtak as lead sponsor.

NCT NCT07401329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07401329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early and Late Neutrophil CD64 and Monocyte HLA-DR as Biomarkers for Septic Shock
Lead sponsor
Pandit Bhagwat Dayal Sharma, PGIMS, Rohtak
Phase
Observational
Overall status
Completed
Start date
January 5, 2019
Completion date
December 31, 2019
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock